Dr Priscilla Gates

Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study

P Gates, H Dhillon, M Krishnasamy, C Wilson, K Gough

(2024), Vol. 32, pp. 1-12, Supportive Care in Cancer, Berlin, Germany, C1

The cancer nursing workforce in Australia: a national survey exploring determinants of job satisfaction

N Bradford, E Moore, K Taylor, O Cook, L Gent, T Beane, N Williams, K Alexander, E Pitt, J Still, C Wellard, G McErlean, D Kirk, L Monterosso, A McCarthy, Z Lokmic-Tomkins, J Balson, P Gates

(2023), Vol. 22, pp. 1-12, BMC Nursing, London, Eng, C1

Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-study

Priscilla Gates, Haryana Dhillon, Karla Gough, Carlene Wilson, Eliza Hawkes, Lindsay Scudder, Tania Cushion, Meinir Krishnasamy

(2022), Vol. 30, pp. 1331-1339, Supportive Care in Cancer, Berlin, Germany, C1-1

Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study

Priscilla Gates, Meinir Krishnasamy, Carlene Wilson, Eliza Hawkes, Vincent Dore, Yuliya Perchyonok, Christopher Rowe, Adam Walker, Janette Vardy, Michiel de Ruiter, Tania Cushion, Haryana Dhillon, Karla Gough

(2022), Vol. 30, pp. 7731-7743, Supportive Care in Cancer, Berlin, Germany, C1-1

Feasibility of an online cognitive rehabilitation programme in patients with a haematological malignancy undergoing autologous stem cell transplantation

Matthew Ku, Priscilla Gates, Steffi Renehan

(2021), Vol. 51, pp. 1665-1672, Internal Medicine Journal, London, Eng., C1-1

Nurses attitudes and practices towards provision of survivorship care for people with a haematological cancer on completion of treatment

Raymond Chan, Elise Button, Alison Thomas, Priscilla Gates, Patsy Yates

(2018), Vol. 26, pp. 1401-1409, Supportive Care in Cancer, Berlin, Germany, C1-1

The Impact of Survivorship Care Planning on Patients, General Practitioners, and Hospital-Based Staff

Linda Nolte, Nicole Kinnane, Julia Lai-Kwon, Priscilla Gates, Pauline Shilkin, Michael Jefford

(2016), Vol. 39, pp. E26-E35, Cancer Nursing, Philadelphia, Pa., C1

Provision of survivorship care for patients with haematological malignancy at completion of treatment: A cancer nursing practice survey study

Ann Wallace, Erin Downs, Priscilla Gates, Alison Thomas, Patsy Yates, Raymond Chan

(2015), Vol. 19, pp. 516-522, EUROPEAN JOURNAL OF ONCOLOGY NURSING, Scotland, C1-1

Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older

L Mileshkin, J Seymour, M Wolf, P Gates, E Januszewicz, P Joyce, H Prince

(2005), Vol. 46, pp. 1575-1579, LEUKEMIA & LYMPHOMA, United States, C1-1

A phase Ib clinical trial of PV70I, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy

H Prince, G Regester, P Gates, L Jablonskis, J Seymour, K Lillie, R West, M Wolf, H Januszewicz, D Belford

(2005), Vol. 11, pp. 512-520, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, United States, C1-1

High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience

A Dowling, H Prince, A Wirth, M Wolf, E Januszewicz, S Juneja, J Seymour, P Gates, J Smith

(2001), Vol. 31, pp. 279-289, INTERNAL MEDICINE JOURNAL, Australia, C1-1

Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: Results of a Phase I study

H Prince, D Rischin, M Quinn, D Allen, R Planner, D Neesham, P Gates, J Davison

(2001), Vol. 81, pp. 216-224, GYNECOLOGIC ONCOLOGY, United States, C1-1

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study

H Prince, D Rischin, G Toner, J Seymour, D Blakey, P Gates, S Eerhard, P Chapple, M Quinn, M Brettell, S Juneja, M Wolf, E Januszewicz, G Richardson, J Scarlett, P Briggs

(2000), Vol. 26, pp. 955-961, BONE MARROW TRANSPLANTATION, England, C1-1

Docetaxel effectively mobilizes peripheral blood CD34(+) cells

H Prince, G Toner, J Seymour, D Blakey, P Gates, S Eerhard, P Chapple, D Wall, M Quinn, S Juneja, M Wolf, E Januszewicz, G Richardson, J Scarlett, P Briggs, M Brettell, D Rischin

(2000), Vol. 26, pp. 483-487, BONE MARROW TRANSPLANTATION, England, C1-1

Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer

H Prince, J Gardyn, M Millward, D Rischin, P Francis, P Gates, P Chapple, M Quinn, S Juneja, M Wolf, E Januszewicz, G Richardson, J Scarlett, P Briggs, M Brettell, G Toner

(1999), Vol. 23, pp. 427-435, BONE MARROW TRANSPLANTATION, England, C1-1

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study

H Prince, M Millward, D Rischin, D Blakey, P Francis, P Gates, P Chapple, M Quinn, S Juneja, M Wolf, E Januszewicz, J Seymour, M Brettell, A Strickland, J Zalcberg, G Richardson, J Scarlett, P Briggs, G Toner

(1999), Vol. 10, pp. 479-481, ANNALS OF ONCOLOGY, England, C1-1

Comparison of COBE (R) Spectra (TM) software version 4.7 PBSC and version 6.0 auto PBSC (TM) program

R Wilke, M Brettell, H Prince, M Wolf, R McKenna, E Serpell, M Molloy, H Stevens, M Quinn, P Gates, P Chapple

(1999), Vol. 14, pp. 26-30, JOURNAL OF CLINICAL APHERESIS, United States, C1-1